Livestock Methane — Two Responses to Agriculture's Largest Emissions Problem

Agriculture contributes nearly half of all anthropogenic methane emissions globally, according to the Food and Agriculture Organization of the United Nations. Within agriculture, cattle systems — beef and dairy combined — generate 3.8 gigatons of CO₂-equivalent per year, representing 62% of total livestock greenhouse gas output. Enteric fermentation, the digestive process in which ruminant stomachs produce methane as a byproduct of breaking down plant material, accounts for the largest single share of those emissions. Two approaches have crossed from research into commercial deployment at scale: a biochemical feed additive that directly inhibits the enzyme responsible for enteric methane formation, and plant-based meat manufacturing, which addresses cattle emissions by reducing the cattle population required to meet protein demand.

The Scale of the Problem

The world's cattle population numbers approximately 1.5 billion animals distributed across every inhabited continent. Beef production alone accounts for two-thirds of livestock greenhouse gas emissions, with FAO data documenting that beef generates approximately 295 kg of CO₂-equivalent per kilogram of protein produced — by comparison, chicken production averages below 50 kg CO₂-equivalent per kilogram of protein. Emissions from livestock enteric fermentation and manure management rose by 4–5% between 2015 and 2020 and, absent intervention, are projected to continue increasing as global demand for animal protein grows toward a 20% increase by 2050 according to FAO modeling.

Enteric methane specifically accounts for approximately 14.9% of total agricultural greenhouse gas emissions in the United States, with beef cattle responsible for 71% of domestic enteric fermentation emissions and dairy cattle for 25%, according to the U.S. Environmental Protection Agency's 2024 inventory. The concentration of emissions in cattle systems — versus pigs and poultry, which produce substantially lower emissions per kilogram of protein — means that interventions targeting cattle have a proportionately larger effect on the agricultural emissions profile than their livestock population share alone would suggest.

Two other mitigation categories deserve brief mention. Seaweed-based feed additives — particularly the red seaweed Asparagopsis taxiformis, which contains bromoform as its active methane-inhibiting compound — have demonstrated methane reductions of 30–90% in trials, and are approved for commercial use in Australian beef feedlots. However, scalable aquaculture production of the seaweed remains logistically unresolved, bromoform is classified as a probable human carcinogen with ongoing safety research, and palatability issues in cattle have been documented in multiple trials. Selective livestock breeding for low-methane genotypes and archaeal-targeted vaccines that suppress methane-producing microbes in the rumen are both in experimental or early-commercial stages, with current reductions from selective breeding estimated at below 10%. This article focuses on the two approaches that have cleared regulatory approval across multiple major markets and reached commercial farm-level deployment.

Scientific Basis

Bovaer's active compound, 3-nitrooxypropanol (3-NOP), targets methyl-coenzyme M reductase — the enzyme that catalyzes the final step in enteric methane production within the rumen of cattle and other ruminants. By inhibiting this enzyme, Bovaer interrupts the methanogenesis pathway without interfering with the broader fermentation processes that enable digestion, nutrient absorption, or feed conversion. The inhibition is rapid, with the compound taking effect within approximately 30 minutes of feeding. Approximately one gram per animal per day is mixed in animal feed and requires no modification to feeding infrastructure.

The compound was developed over more than a decade by dsm-firmenich and has been evaluated in over 150 on-farm trials across 20 countries and more than 110 peer-reviewed studies published in independent scientific journals, as documented by dsm-firmenich's trial registry. The body of independent published research makes 3-NOP the most extensively studied enteric methane inhibitor in the scientific literature to date.

Dairy cattle: enteric fermentation during digestion is the primary source of agricultural methane in most producing countries.

Commercial mixed-feed operation: Bovaer is administered as a powder mixed into daily feed rations at approximately one gram per animal.

DSM-firmenich's research into 3-NOP spanned more than a decade and generated over 110 peer-reviewed publications in independent scientific journals.

Emission Reduction Evidence

Across the published trial base, Bovaer reduces enteric methane emissions by an average of 30% in dairy cattle and 45% in beef cattle, with some individual trials recording reductions of up to 65% under specific feeding conditions. Elanco Animal Health, dsm-firmenich's distribution partner in North America, has stated that feeding one million dairy cows Bovaer daily would reduce methane emissions equivalent to removing approximately 285,000 cars from the road for one year — a figure derived from the 1.2 metric tons of CO₂-equivalent reduction per lactating cow per year that the 30% reduction rate produces at standard U.S. dairy production parameters.

The European Food Safety Authority (EFSA) conducted a safety evaluation prior to the EU's 2022 authorization, concluding that Bovaer presents no adverse effects on animal health, fertility, milk composition, or body weight. The U.S. Food and Drug Administration completed a multi-year review in May 2024 and determined the compound meets safety and efficacy requirements for use in lactating dairy cattle in the United States. Both regulatory conclusions are publicly available in the respective agencies' published decision records.

Deployment, Market Access, and Economics

Bovaer is manufactured exclusively by dsm-firmenich, with large-scale production capacity being developed at a new facility in Dalry, Scotland, with support from Scottish Enterprise. Construction began in late 2022 with completion targeted for 2025. In North America, distribution is handled by Elanco Animal Health under a commercial partnership announced in 2022. In the EU, Australia, and Japan, dsm-firmenich operates direct commercial channels. The single-supplier manufacturing model means the product's global supply is currently concentrated in one company's production infrastructure.

Farm-level cost estimates vary by country and farm type. A 2022 estimate from dsm-firmenich cited approximately $93–105 per cow per year at then-current production costs, equivalent to approximately one cent per liter of milk produced. An Irish farm trial placed the cost at approximately $70 per cow per year. DSM-firmenich has indicated that completion of the Dalry plant is expected to reduce per-unit manufacturing costs toward $50 per cow annually. In commercial deployments to date, the costs are absorbed by dairy processors or food companies seeking to reduce Scope 3 emissions in their supply chains — Elanco has characterized Bovaer as creating a self-sustaining carbon inset market in which downstream food companies fund adoption in exchange for verified emission reductions attributable to their purchased milk.

Scientific basis

Plant-based meat addresses livestock methane through demand substitution rather than direct biochemical intervention. By replacing one kilogram of beef in the diet with a plant-derived protein product, the emissions associated with raising, feeding, and processing a cattle animal to produce that kilogram are avoided entirely — including enteric methane, feed crop emissions, land-use change, manure management, and slaughter processing.

A 2024 peer-reviewed LCA conducted by UK researchers and published in the journal Sustainability found that a plant-based burger patty produced a 65% reduction in global warming potential and a 45% reduction in water consumption compared to its beef burger equivalent, using a cradle-to-fork system boundary. The study extrapolated that if the UK population substituted beef patties for plant-based patties across relevant consumption occasions, 3 million tonnes of CO₂-equivalent could be saved annually — equivalent to 0.74% of the UK's total annual territorial emissions.

Independent lifecycle analyses of Beyond Meat and Impossible Foods products report greenhouse gas emission reductions of approximately 89–90% compared to conventionally produced US feedlot beef, with comparable reductions in land and water use. A November 2024 comparative LCA published by the Good Food Institute, prepared by Earthshift Global (Bonales et al. 2024), confirmed that plant-based meat systems have low environmental impacts across 18 measured categories and can be scaled with proportionally lower natural resource use than animal systems.

Plant-based burger products designed to replicate the texture and flavour profile of beef: multiple independent lifecycle assessments document 65–90% lower GHG emissions compared to conventional beef.

Pea, soy, and wheat proteins form the primary ingredient base for commercial plant-based meat products — all with substantially lower cultivation emissions than livestock feed conversion chains.

Mainstream retail distribution has expanded the accessible market for plant-based products beyond specialist channels into conventional grocery environments across more than 50 countries.

Plant-based meat manufacturing has attracted over $5 billion in investment across the past five years, funding production capacity expansion in North America, Europe, and the Asia-Pacific region.

Market Scale, Investment, and Supplier Ecosystem

The global plant-based meat market was valued at approximately $17.1 billion in 2024, with projections across multiple market research sources ranging from $54.8 billion to over $100 billion by 2033–2035, depending on methodology. Unlike Bovaer, the plant-based meat market encompasses a large number of competing manufacturers. Prominent producers include Beyond Meat (publicly traded, NASDAQ: BYND), Impossible Foods (private, total funding approximately $2 billion), Quorn Foods, Nestlé, Maple Leaf Foods, Heura Foods, NotCo, Kellogg's, and dozens of regional producers in Europe, Asia-Pacific, and South America. Plant-based meat companies collectively raised over $5 billion in investment across the five years to 2024. The market structure is multi-supplier and competitive, with no single company controlling production, pricing, or distribution in the way dsm-firmenich controls Bovaer's supply chain.

Products are distributed across more than 50 countries through conventional retail, foodservice, and e-commerce channels. North America holds the largest market share at approximately 40% of global volume as of 2024, with the Asia-Pacific region growing at the fastest rate — approximately 18.9% compound annual growth — driven by urbanisation, rising incomes, and government-backed sustainability initiatives in China, Singapore, and Japan. China's national dietary guidelines explicitly encourage a 50% reduction in meat consumption, and Singapore and Japan have designated alternative protein development as innovation priorities.

Commercial Headwinds

Beyond Meat's public SEC filings document a period of declining revenues across 2022–2024 in U.S. retail and foodservice channels. U.S. retail net revenues declined 16% in Q1 2024, 22.6% in Q3 2024, and the company attributed the declines to "weak category demand" and consumer ambiguity about the health profile of plant-based products. Impossible Foods, which remains private, has not published revenue data, but independent reports indicate no equivalent public disclosure of growth. The market-level slowdown in the United States contrasts with continued growth in European and Asia-Pacific markets, suggesting regional variation in adoption patterns tied to consumer attitudes toward food processing and nutritional labelling.

What the Evidence Record Shows

Bovaer and plant-based meat address the same emissions source through different mechanisms and at different points in the food production chain. Bovaer operates within the existing cattle industry, targeting the biochemical pathway of methane formation and leaving the animal husbandry, land use, and consumption patterns of the sector unchanged. Plant-based meat targets the demand side, reducing the number of cattle required to meet protein needs and thereby reducing all emission categories associated with cattle production, not only enteric methane.

The two approaches also carry different adoption profiles. Bovaer requires farmer uptake, feed management changes, and cost recovery through either premium milk pricing or supply chain funding from food processors. Its single-manufacturer structure concentrates supply chain risk. Plant-based meat requires consumer substitution and must compete on price and sensory experience with conventional animal protein — adoption challenges that have been documented in declining US revenues at Beyond Meat between 2022 and 2024. The competitive multi-manufacturer structure of the plant-based sector means no single commercial failure undermines the category, but the market fragmentation also disperses investment and slows the price convergence with conventional meat that most analysts identify as the threshold for mainstream adoption at scale.